BGP-32543

N/A

Report date: 2026/01/19 17:22:49
NME

Base Information

Drug NameBGP-32543
Drug Alias NameBGP-32543BGP32543
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein farnesyltransferase inhibitors
TargetsProtein farnesyltransferase
Therapy Area/IndicationsSolid tumoursCarcinoma, Transitional CellSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBridGene Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBridGene Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Transitional CellSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A